Company Filing History:
Years Active: 2019
Title: Michael Peter Vanbrunt: Innovator in Antibody Derivatives
Introduction
Michael Peter Vanbrunt is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody derivatives. His work focuses on innovative therapeutic solutions that address critical health issues.
Latest Patents
Michael Peter Vanbrunt holds a patent for his invention related to antibody derivatives. The patent describes a bivalent, bispecific construct that includes an anti-IL-6 antibody and an anti-IL-23 antibody. This invention has potential applications in therapy, providing useful anti-IL-6 and anti-IL-23 antibodies for medical use.
Career Highlights
Michael is currently employed at MedImmune Limited, a leading biotechnology company. His role involves research and development in the field of antibody therapies. His expertise and innovative approach have positioned him as a key contributor to advancements in this area.
Collaborations
Throughout his career, Michael has collaborated with esteemed colleagues, including Kenneth H Grabstein and William Brady. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking therapeutic solutions.
Conclusion
Michael Peter Vanbrunt is a distinguished inventor whose work in antibody derivatives has the potential to transform therapeutic approaches in medicine. His contributions continue to impact the field of biotechnology positively.